Addus HomeCare (ADUS)
(Delayed Data from NSDQ)
$104.96 USD
-1.82 (-1.70%)
Updated Aug 1, 2025 04:00 PM ET
After-Market: $105.03 +0.07 (0.07%) 7:58 PM ET
3-Hold of 5 3
B Value A Growth C Momentum A VGM
Fundamental Charts
About Cash from Investing (TTM)
The company's trailing twelve month (TTM) Cash from Investing is the sum of the company's past 12 months cash position resulting from any gains or losses from investments in the financial markets, operating activities, and changes resulting from amounts spent on investments in capital assets such as plant and equipment. When evaluating the Cash from Investing value, it is important to consider each of the various activities which contribute to the overall change in cash position. A company can have a negative cash flow from investing and have a positive cash from Cash from operations or financing.
ADUS 104.96 -1.82(-1.70%)
Will ADUS be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for ADUS based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for ADUS
Amedisys (AMED) Beats Q2 Earnings and Revenue Estimates
Brookdale's Occupancy Registers a Rise to 80.5% in June 2025
ADUS: What are Zacks experts saying now?
Zacks Private Portfolio Services
ADUS vs. USPH: Which Stock Should Value Investors Buy Now?
Do Options Traders Know Something About Addus HomeCare Stock We Don't?
BTSG Raises 2025 Financial Outlook: What's Backing It?
Other News for ADUS
Addus HomeCare Q2 2025 Earnings Preview
Addus HomeCare Corp (ADUS) Announces Q2 2025 Earnings Release Date | ADUS stock news
Addus HomeCare Announces Second Quarter 2025 Earnings Release and Conference Call | ADUS Stock News
TimesSquare U.S. Small Cap Growth Strategy Q2 2025 Commentary
Addus HomeCare (ADUS) Sees Analyst Reiteration with Maintained Price Target | ADUS Stock News